These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9638235)

  • 1. [Clinical picture of acute myocardial infarction depending on the use of pharmacologic treatment schemes].
    Jankowska A; Sarachman K; Drozd J; Palusiński R; Kudlicki J
    Wiad Lek; 1995; 48(1-12):175-9. PubMed ID: 9638235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
    Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptokinase in recent myocardial infarction: a controlled multicentre trial. European working party.
    European Working Party
    Br Med J; 1971 Aug; 3(5770):325-31. PubMed ID: 4934187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial revascularization in the developing phase of myocardial infarction using intracoronary thrombolytic therapy].
    Puel J; Miquel JP; Massabuau P; Cassagneau B; Miluau S; Fauvel JM; Bounnoure JP
    Rev Med Univ Navarra; 1984 Dec; 28(4):43-6. PubMed ID: 6528151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
    Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E
    Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ST-segment trend in patients with acute myocardial infarction treated with antithrombotic drugs (author's transl)].
    Compostella L; Russo R; Nascimben L; Prandoni P; Schivazappa L
    G Ital Cardiol; 1981; 11(11):1762-74. PubMed ID: 7343381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptokinase and enoxaparin in the pre-hospital management of the ST-segment elevation acute myocardial infarction.
    Tatu-Chiţoiu G; Oprişan M; Cismara O; Marinescu R; Marinescu A
    Rom J Intern Med; 2002; 40(1-4):11-25. PubMed ID: 15526537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).
    Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M
    Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.
    Schröder R; Zeymer U; Wegscheider K; Neuhaus KL
    Eur Heart J; 1999 Nov; 20(21):1563-71. PubMed ID: 10529324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.